DEPLOY

Buying guide

Versius

By CMR Surgical · surgical

Price
$750,000-$1,000,000· analyst estimate
Availability
Internal use only (not for retail).
Maturity
commercial
Real-world use
Yes, 2 verified deployments

CMR Surgical's Versius (and Versius Plus) is a modular, multi-arm, soft-tissue minimal-access surgical robot from UK-based CMR Surgical, and the international-soft-tissue archetype of DEPLOY's surgical cluster. Its modular multi-arm architecture is a deliberate contrast to the monolithic design of Intuitive's da Vinci: it is teleoperated and software-driven, capturing telematic, video, and outcome data. On regulatory status (a correction worth recording): Versius is US-FDA-cleared for cholecystectomy via a De Novo authorization in October 2024, with Versius Plus cleared via 510(k) on December 18, 2025 (also cholecystectomy) and a gynecology 510(k) submitted April 29, 2026 (pending); it is not broadly 'US-pending', only the gynecology indication is. It is CE-marked and commercial across Europe, Latin America, AMEA, and Australia. As enterprise B2B surgical equipment sold to hospitals, there is no consumer price.

Readiness

Versius is internal use only (not for retail) at $750,000-$1,000,000 (analyst estimate), the 1 capability claim on file is all teleoperated-assisted with claimed, 2 verified deployments are on file, and no incidents are on record.

Availability
internal-only

Internal use only (not for retail).

see evidence →

Price honesty
analyst-estimate

One price on file: $750,000-$1,000,000 (analyst estimate).

see evidence →

Capability honesty
teleoperated-assisted

1 reviewed claim: teleoperated-assisted, claimed.

see evidence →

Real-world use
commercial

Maturity: commercial. 2 verified deployments in the registry.

see evidence →

Safety record
no-incidents

No incidents on record. 2 verified deployments on file.

What it claims to do

Price

Real-world use

Safety record

No incidents on record. 2 verified deployments on file.

Privacy

No privacy practices disclosed or on file for Versius.

Specs

arms
multi-arm
notes
  • Verified: CMR Surgical (founded 2014, Cambridge UK; private) makes Versius, the genuine challenger that crossed the gating event: FDA De Novo Oct 2024 (first De Novo for a multi-port soft-tissue general-surgery robot), FDA 510(k) for next-gen Versius Plus Dec 18 2025 (US commercialization on track for 2026), plus a pending gynecology 510(k) (Apr 29 2026). >40,000 procedures completed ex-US (company-reported). Recapitalized with $200M+ in Apr 2025.
  • Current-state correction (peak-era framing stale): The 2021 ~$3B SoftBank-led valuation story is frozen. The company went through real 2023 restructuring (~350 redundancies). REJECTED as unverified aggregator/rumor-tier: a ~$3.1B 2025 valuation and a ~$4B sale-exploration; current valuation is unconfirmed (cap-flag).
  • AI-substance: R&D-stage (honest): Shipped substance = data-capture + analytics ecosystem (teleoperated, surgeon in full control). The 'physical AI' is forward-looking: a Mar 2026 NVIDIA IGX Thor partnership to EVALUATE AI for next-gen Versius (~500 hrs anonymized data contributed). No autonomous/AI-assist intraoperative feature is FDA-cleared or shipped.
  • Claimed but NOT verified: ~$3.1B current valuation; ~$4B sale exploration; exact installed unit count (procedure-count >40k is self-reported); any AI-assist feature being commercially available; gynecology indication (submitted, not cleared).
products
Versius / Versius Plus: modular multi-arm soft-tissue minimal-access robot; teleoperated, software-driven (captures telematic/video/outcome data). FDA De Novo Oct 2024 (Versius, cholecystectomy); FDA 510(k) Dec 18 2025 (Versius Plus, cholecystectomy); 510(k) gynecology submission Apr 29 2026 (pending). CE-marked + commercial across Europe, Latin America, AMEA, Australia.
formFactor
surgical (modular multi-port / multi-arm teleoperated soft-tissue surgical robot)
fda_clearance
De Novo marketing authorization in October 2024
clearance_body
US FDA
procedure_types
cholecystectomy

What's under the hood

No brain on file for Versius.

Frequently asked questions

Is the Versius actually available for purchase?
Not available to consumers. In internal use by CMR Surgical.Source: CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)
What does the Versius cost?
Versius costs $750,000-$1,000,000 one-time (analyst estimate).Source: How Much is a Surgical Robot? — R2 Surgical industry pricing guide
Does the Versius really assists surgery?
Claimed at teleoperator-assisted autonomy; verification status: claimed.Sources: Versius Surgical System -- CMR Surgical product page; portable modular robotic system for minimally invasive laparoscopic surgery; commercially deployed in UK NHS and international hospitals, Robot performs first keyhole surgery in Britain -- BBC Health, January 2020; Versius used in first UK minimally invasive procedure at Bedford Hospital; documents commercial adoption in NHS
Where is the Versius being used?
Versius is in use at: India (2022-01-01) and United Kingdom (2019-01-01).Source: First Versius installations in India
Is the Versius safe?
No incidents on record across 2 verified deployments.
How does the Versius handle privacy?
No privacy practices disclosed or on file for Versius.
Who makes the Versius?
Versius is made by CMR Surgical, based in Cambridge, United Kingdom.Source: CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)

Video

PRIMARY SOURCE
Courtesy of CMR Surgical

CMR Surgical's overview of Versius Plus, framed around freedom of access by design. The system is surgeon-teleoperated, never autonomous.

PRIMARY SOURCE
Courtesy of CMR Surgical

CMR Surgical's footage of a robotic cholecystectomy performed on Versius at Manchester Royal Infirmary. Surgeon-teleoperated, never autonomous.

PRIMARY SOURCE
Courtesy of CMR Surgical

CMR Surgical's introduction of its Versius surgical robotic system. A surgeon teleoperates Versius from a console; it is never autonomous.

Manufacturer

CMR Surgical (registry record: /companies/cmr-surgical)

Compare side by side

Sources

  1. CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024) · https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo
  2. CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026) · https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/
  3. CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025) · https://www.massdevice.com/cmr-surgical-200-million-funding/
  4. CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage) · https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor
  5. CMR Surgical 2023 redundancies (~350; historical restructuring) · https://www.cambridgeindependent.co.uk/news/cmr-surgical-redundancies
  6. Versius Surgical System -- CMR Surgical product page; portable modular robotic system for minimally invasive laparoscopic surgery; commercially deployed in UK NHS and international hospitals · https://cmrsurgical.com/versius
  7. Robot performs first keyhole surgery in Britain -- BBC Health, January 2020; Versius used in first UK minimally invasive procedure at Bedford Hospital; documents commercial adoption in NHS · https://www.bbc.com/news/health-51058827 · 2020-01-24
  8. CMR Surgical official YouTube (@CMRSurgical), embedded under standard YouTube embed terms. oEmbed author_url verified 2026-06. · https://www.youtube.com/watch?v=a9mXmmhMKqY · 2026-06-05
  9. How Much is a Surgical Robot? — R2 Surgical industry pricing guide · https://r2surgical.com/blogs/news/how-much-is-a-new-surgical-robot
  10. First Versius installations in India · https://cmrsurgical.com/news/cmrsurgical-announces-first-versius-installations-in-india/
  11. Versius robotic surgery enters India · https://www.thehindu.com/sci-tech/health/versius-robotic-surgery-india/article67890123.ece
  12. AIMS Faridabad introduces Versius · https://www.expresshealthcare.in/news/aims-introduces-versius-robotic-surgical-system/437699/
  13. 20,000+ Versius cases globally · https://cmrsurgical.com/news/over-20000-surgical-cases-completed-using-versius
  14. India and Middle East business update · https://cmrsurgical.com/news/cmr-surgical-india-middle-east-business-update
  15. Versius India economics analysis · https://robochronicle.com/can-surgical-robots-move-downmarket-cmr-surgicals-versius-test-in-india-and-the-economics-of-smaller-hospitals/
  16. Versius surgical robot · https://cmrsurgical.com/versius/
  17. Versius reaches procedure milestone · https://cmrsurgical.com/news/versius-procedure-milestone/
  18. Royal Papworth Cambridge Versius thoracic Mar 2023 · https://www.royalpapworth.nhs.uk/our-hospital/latest-news/new-thoracic-surgery-robot-bought-royal-papworth-uk-first
  19. BBC: Royal Papworth robot thoracic surgery · https://www.bbc.co.uk/news/uk-england-cambridgeshire-65039708
  20. Addenbrookes Cambridge Versius Jul 2023 · https://www.cambridge-news.co.uk/news/cambridge-news/addenbrookes-hospital-gets-new-surgical-27253650
  21. Milton Keynes second Versius Sep 2024 · https://www.mkuh.nhs.uk/news/mkuh-purchases-second-versius-system-to-bring-robotic-surgery-to-more-patients

Recent coverage

See all coverage →

Machine-readable: this page as markdown.

Canonical: https://deploy.report/models/cmr-versius